Clinical Trial Update: A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating zidovudine in HIV-infected patients with hemophilia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED